ClinicalTrials.Veeva

Menu

Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer

R

Radboud University Medical Center

Status

Unknown

Conditions

Colorectal Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT00220246
EOMSD2004

Details and patient eligibility

About

Two major genetic pathways leading to colorectal carcinoma can well be distinguished; the 'suppressor pathway', which is characterized by inactivation of tumor-suppressor genes and the 'mutator pathway', which is characterized by microsatellite instability. The purpose of this study is to explore a third putative pathway; microsatellite and chromosome stable colorectal cancer where an alternative cancer-causative mechanism might play a role.

Full description

Patients with familial colorectal cancer will be characterized with respect to family history, medical history and demographic characteristics. The histopathology of the tumors will be reviewed. Tumor specimens will be analysed on molecular defects.

Sex

All

Ages

Under 51 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Colorectal cancer before the age of 51 years

Microsatellite stable tumor

Exclusion criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems